| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..10315154C |
| P356 | DOI | 10.1073/PNAS.0607002103 |
| P932 | PMC publication ID | 1622792 |
| P698 | PubMed publication ID | 17005719 |
| P5875 | ResearchGate publication ID | 6788419 |
| P2093 | author name string | Lisa M Harrison | |
| Michael Cappello | |||
| Raffi V Aroian | |||
| Joel S Griffitts | |||
| Richard D Bungiro | |||
| Larry J Bischof | |||
| Brad D Barrows | |||
| P2860 | cites work | Bacillus thuringiensis crystal proteins that target nematodes | Q24554220 |
| Patterns of geohelminth infection, impact of albendazole treatment and re-infection after treatment in schoolchildren from rural KwaZulu-Natal/South-Africa | Q24801560 | ||
| "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor | Q24810845 | ||
| Bacterial insecticidal toxins | Q28259153 | ||
| Soil-transmitted helminth infections: updating the global picture | Q29619026 | ||
| Safety and advantages of Bacillus thuringiensis-protected plants to control insect pests | Q33924446 | ||
| How Bacillus thuringiensis has evolved specific toxins to colonize the insect world | Q33940103 | ||
| Phosphorylcholine substituents in nematodes: structures, occurrence and biological implications | Q34081441 | ||
| Dietary iron content mediates hookworm pathogenesis in vivo. | Q34301207 | ||
| Veterinary anthelmintics: old and new. | Q34550770 | ||
| Bacillus thuringiensis (Bt) toxin susceptibility and isolation of resistance mutants in the nematode Caenorhabditis elegans | Q34610254 | ||
| Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes | Q35126813 | ||
| Methods to sustain drug efficacy in helminth control programmes | Q35126826 | ||
| Human gastrointestinal helminth infections: are they now neglected diseases? | Q35569088 | ||
| Bt: mode of action and use. | Q35591820 | ||
| Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control | Q35680581 | ||
| Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. | Q35744749 | ||
| Drug resistance in veterinary helminths | Q35885282 | ||
| Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. | Q35921558 | ||
| Anthelmintic resistance--looking to the future: a UK perspective | Q35962864 | ||
| Will technology provide solutions for drug resistance in veterinary helminths? | Q36238833 | ||
| Two different parasporal inclusions are produced by Bacillus thuringiensis subsp. finitimus | Q36280930 | ||
| Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms | Q38447215 | ||
| Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali | Q38463813 | ||
| Bacillus thuringiensis Delta-Endotoxin Cry1 Hybrid Proteins with Increased Activity against the Colorado Potato Beetle | Q39493313 | ||
| Soil-transmitted nematode infections and mebendazole treatment in Mafia Island schoolchildren | Q39640026 | ||
| Detection of excretory/secretory coproantigens in experimental hookworm infection | Q40373442 | ||
| Insecticidal bacteria: an overwhelming success for invertebrate pathology | Q42040271 | ||
| Ancylostoma Ceylanicum Infection in Dogs, Cats, and Man in Taiwan | Q43211869 | ||
| Glycolipids as receptors for Bacillus thuringiensis crystal toxin | Q44244780 | ||
| Evolution of high-level, multiple anthelmintic resistance on a sheep farm in Malaysia | Q44361381 | ||
| Rapid selection for ivermectin resistance in Haemonchus contortus | Q44684438 | ||
| Bt toxin resistance from loss of a putative carbohydrate-modifying enzyme | Q45167150 | ||
| Toxicity of Bacillus thuringiensis to parasitic and free-living life-stages of nematode parasites of livestock | Q46554624 | ||
| Assessment of the effect of gastrointestinal nematode infestation on weight gain in grazing beef cattle | Q47388211 | ||
| Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia | Q50904249 | ||
| Ancylostoma ceylanicum in the hamster: observations on the host-parasite relationship during primary infection | Q52868229 | ||
| Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum | Q54013517 | ||
| Ancylostoma Ceylanicum: a Parasite of Man in Calcutta and Environs * | Q70372155 | ||
| Action starts now to control disease due to schistosomiasis and soil-transmitted helminthiasis | Q73389767 | ||
| Extending the benefits of deworming for development | Q81706455 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bacillus thuringiensis | Q310467 |
| Ancylostoma ceylanicum | Q16974161 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 15154-15159 | |
| P577 | publication date | 2006-09-27 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum | |
| P478 | volume | 103 |
| Q39272441 | A Novel Fucose-binding Lectin from Photorhabdus luminescens (PLL) with an Unusual Heptabladed β-Propeller Tetrameric Structure |
| Q36432948 | A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases(). |
| Q33375026 | Activation of the unfolded protein response is required for defenses against bacterial pore-forming toxin in vivo. |
| Q28829800 | Anthelmintic Effect of Bacillus thuringiensis Strains against the Gill Fish Trematode Centrocestus formosanus |
| Q37123637 | Bacillus subtilis Strain Engineered for Treatment of Soil-Transmitted Helminth Diseases |
| Q90086294 | Bacillus thuringiensis Cry5B is Active against Strongyloides stercoralis in vitro |
| Q54208548 | Bacillus thuringiensis Cry5B protein as a new pan-hookworm cure. |
| Q28473074 | Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice |
| Q35900236 | Bacillus thuringiensis Crystal Protein Cry6Aa Triggers Caenorhabditis elegans Necrosis Pathway Mediated by Aspartic Protease (ASP-1). |
| Q28606950 | Bacillus thuringiensis Is an Environmental Pathogen and Host-Specificity Has Developed as an Adaptation to Human-Generated Ecological Niches |
| Q28534011 | Bacillus thuringiensis-derived Cry5B has potent anthelmintic activity against Ascaris suum |
| Q37469105 | Bacterial pore-forming proteins as anthelmintics |
| Q37384521 | Characterisation of a fatty acid and retinol binding protein orthologue from the hookworm Ancylostoma ceylanicum. |
| Q111346869 | Characterization of eight Bacillus thuringiensis isolates originated from fecal samples of Fuzhou Zoo and Fuzhou Panda Center |
| Q46296839 | Controlling gastrointestinal nematodes in cattle by Bacillus species |
| Q28480978 | Cure of Hookworm Infection with a Cysteine Protease Inhibitor |
| Q24658119 | Developing novel anthelmintics from plant cysteine proteinases |
| Q92488284 | Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics |
| Q33778375 | Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility |
| Q34453985 | Divergence of the SigB regulon and pathogenesis of the Bacillus cereus sensu lato group |
| Q27674416 | Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors |
| Q38621427 | Entomotoxic and nematotoxic lectins and protease inhibitors from fungal fruiting bodies. |
| Q34875733 | Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: Patterns of malaria coinfection, anemia, and albendazole treatment failure |
| Q56768358 | In VitroOvicidal and Cestocidal Effects of Toxins fromBacillus thuringiensison the Canine and Human ParasiteDipylidium caninum |
| Q37456181 | In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility |
| Q54157122 | In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasites |
| Q38386911 | Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic |
| Q40558826 | Larvicidal activity of Bacillus thuringiensis var. israelensis Cry11Aa toxin against Haemonchus contortus |
| Q57283998 | Low translocation ofBacillus thuringiensisisraelensisto inner organs in mice after pulmonary exposure to commercial biopesticide |
| Q28484987 | Mechanistic and Single-Dose In Vivo Therapeutic Studies of Cry5B Anthelmintic Action against Hookworms |
| Q35697108 | Molecular cloning and characterization of a C-type lectin from Ancylostoma ceylanicum: evidence for a role in hookworm reproductive physiology |
| Q51790901 | Mucosal antibody responses in experimental hookworm infection |
| Q37290813 | Odanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In Vivo |
| Q92557035 | Omics Driven Understanding of the Intestines of Parasitic Nematodes |
| Q36115719 | Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target |
| Q41252057 | Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles |
| Q34673172 | RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. |
| Q46024767 | Resistance to Bacillus thuringiensis toxin in Caenorhabditis elegans from loss of fucose. |
| Q42002175 | Responses of 9 lepidopteran species to Bacillus thuringiensis: How useful is phylogenetic relatedness for selecting surrogate species for nontarget arthropod risk assessment? |
| Q36710725 | Role for nitric oxide in hookworm-associated immune suppression |
| Q89982892 | Sensory cilia as the Achilles heel of nematodes when attacked by carnivorous mushrooms |
| Q58951737 | Soil bacteria could yield drug to treat roundworm |
| Q27675127 | Structure and Glycolipid Binding Properties of the Nematicidal Protein Cry5B |
| Q90421925 | Suppressing a plant-parasitic nematode with fungivorous behavior by fungal transformation of a Bt cry gene |
| Q52619241 | Target-based and whole-worm screening approaches to anthelmintic discovery |
| Q39451885 | The Global State of Helminth Control and Elimination in Children |
| Q34125793 | The drugs we have and the drugs we need against major helminth infections |
| Q34117229 | The pore-forming protein Cry5B elicits the pathogenicity of Bacillus sp. against Caenorhabditis elegans |
| Q38439867 | The requirement for early exposure of Haemonchus contortus larvae to Bacillus thuringiensis for effective inhibition of larval development |
| Q42029130 | The theoretical 3D structure of Bacillus thuringiensis Cry5Ba |
| Q38925668 | Twenty-First Century Progress Toward the Global Control of Human Hookworm Infection |
| Q33538090 | WWP-1 is a novel modulator of the DAF-2 insulin-like signaling network involved in pore-forming toxin cellular defenses in Caenorhabditis elegans |
| Q34001863 | Whole-genome phylogenies of the family Bacillaceae and expansion of the sigma factor gene family in the Bacillus cereus species-group |
Search more.